Thyroid nodules are common, usually asymptomatic, and often pose minimal risk to the
affected patient. However, 10–15% prove malignant and serve as the rationale for …

Substantial developments have occurred in the past 5–10 years in clinical translational
research of thyroid cancer. Diagnostic molecular markers, such as RET-PTC, RAS, and …

Background: Thyroid disease in pregnancy is a common clinical problem. Since the
guidelines for the management of these disorders by the American Thyroid Association …

The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the
management of different types of thyroid carcinoma, including papillary, follicular, Hürthle …

Importance Use of next-generation sequencing of RNA and machine learning algorithms
can classify the risk of malignancy in cytologically indeterminate thyroid nodules to limit …

BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Background Approximately 15 to 30% of thyroid nodules evaluated by means of fine-needle
aspiration are not clearly benign or malignant. Patients with cytologically indeterminate …

Context: Molecular testing for oncogenic mutations or gene expression in fine-needle
aspirations (FNAs) from thyroid nodules with indeterminate cytology identifies a subset of …

Introduction Over the past years, the incidence of thyroid cancer has surged not only in
Germany but also in other countries of the Western hemisphere. This surge was first and …

Background: Recent advances in research on thyroid carcinogenesis have yielded
applications of diagnostic molecular biomarkers and profiling panels in the management of …